Yangyang Liu

College of Traditional Chinese Medicine, Changchun University of Chinese Medicine

Affiliated withChangchun University of Chinese Medicine the Affiliated Hospital to Changchun University of Chinese Medicine

Research Area

Biography

Yangyang Liu has not added Biography.
If you are Yangyang Liu and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2025

Other Publications

Article	Year
Boronic Acid as Glucose-Sensitive Agent Regulates Drug Delivery for Diabetes Treatment. Materials (Basel, Switzerland)\| PubMed ID: 28772528	2017
Effect of vitamin K1 on survival of patients with chronic liver failure: A retrospective cohort study. Medicine\| PubMed ID: 32221088	2020
Efficacy and safety of acupuncture combined with Chinese herbal medicine in the treatment of primary liver cancer: A protocol for systematic review and meta-analysis. Medicine\| PubMed ID: 34622883	2021
Efficacy and safety of acupuncture and moxibustion combined with the external application of traditional Chinese medicine in the treatment of primary liver cancer: A protocol for systematic ... Medicine\| PubMed ID: 34713860	2021
The Biology and Function of Extracellular Vesicles in Cancer Development. Frontiers in cell and developmental biology\| PubMed ID: 34805181	2021
Timely treatment and higher compliance to traditional Chinese medicine: New influencing factors for reducing severe COVID-19 based on retrospective cohorts in 2020 and 2021. Pharmacological research\| PubMed ID: 35288309	2022
Adenosine triphosphate-binding cassette subfamily C members in liver hepatocellular carcinoma: Bioinformatics-driven prognostic value. Medicine\| PubMed ID: 35363194	2022
Targeting Epigenetic Regulatory Enzymes for Cancer Therapeutics: Novel Small-Molecule Epidrug Development. Frontiers in oncology\| PubMed ID: 35419278	2022
The role of lncRNAs and in oral cancer. Frontiers in cell and developmental biology\| PubMed ID: 36035993	2022
Effectiveness and safety analysis of SanHanHuaShi granules for the treatment of coronavirus disease 2019: Study protocol and statistical analysis plan for a randomized, parallel-controlled, ... Frontiers in pharmacology\| PubMed ID: 36052134	2022
Association with the plasma atherogenic index with hepatic steatosis and fibrosis in the US population. Medicine\| PubMed ID: 38394523	2024
Oral nano-formulations for endocrine therapy of endometrioid adenocarcinomas. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie\| PubMed ID: 39243435	2024
Correlation Analysis of Traditional Chinese Medicine Constitution and Metabolic Indexes in General Physical Examination People. Endocrine, metabolic & immune disorders drug targets\| PubMed ID: 39364874	2025
Recent advances in the treatment of non-small cell lung cancer with MET inhibitors. Frontiers in chemistry\| PubMed ID: 39720556	2024
Hua Zheng San Ji Fang suppresses liver cancer progression by inhibiting TYRO3 expression via the ERK signaling pathway. Phytomedicine : international journal of phytotherapy and phytopharmacology\| PubMed ID: 40023065	2025
Epigenetic targets and their inhibitors in the treatment of idiopathic pulmonary fibrosis. European journal of medicinal chemistry\| PubMed ID: 40048798	2025
Small molecular inhibitors targeting Janus kinases (JAKs) for the treatment of psoriasis. European journal of medicinal chemistry\| PubMed ID: 40592184	2025
Preliminary study on metabolite differences between two obesity syndromes based on Q Exactive liquid chromatography-tandem mass spectrometry metabolomics. PloS one\| PubMed ID: 40929178	2025
The association of multiple metabolic disorders with the severity of fasting blood glucose and hepatic steatosis in a Chinese population with MAFLD: a cross-sectional study of over 3000 part... Scientific reports\| PubMed ID: 41381661	2025